Docosahexaenoic acid activates some SREBP-2 targets independent of cholesterol and ER stress in SW620 colon cancer cells

Lipids. 2009 Aug;44(8):673-83. doi: 10.1007/s11745-009-3324-4. Epub 2009 Jul 7.

Abstract

The SREBP-2 transcription factor is mainly activated by low cellular cholesterol levels. However, other factors may also cause SREBP-2 activation. We have previously demonstrated activation of SREBP-2 by the polyunsaturated fatty acid docosahexaenoic acid (DHA) in SW620 colon cancer cells. Despite activation of SREBP-2, only a few target genes were induced and cholesterol biosynthesis was reduced. In the present study, gene expression analysis at early time points verified the previously observed SREBP-2 target gene expression pattern. Activation of SREBP-2 using siRNAs targeting Niemann Pick C1 protein (NPC1) led to increased expression of all SREBP target genes examined, indicating that activation of some SREBP-2 target genes is inhibited during DHA-treatment. Cholesterol supplementation during DHA treatment did not abolish SREBP-2 activation. We also demonstrate that activation of SREBP-2 is independent of ER stress and eIF2alpha phosphorylation, which we have previously observed in DHA-treated cells. Thapsigargin-induced ER stress repressed expression of SREBP-2 target genes, but with a different pattern than observed in DHA-treated cells. Moreover, oleic acid (OA) treatment, which does not induce ER stress in SW620 cells, led to activation of SREBP-2 and induced a target gene expression pattern similar to that of DHA-treated cells. These results indicate that DHA and OA may activate SREBP-2 and inhibit activation of SREBP-2 target genes through a mechanism independent of cholesterol level and ER stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / genetics*
  • Adenocarcinoma / metabolism
  • Cell Cycle / drug effects
  • Cell Cycle / genetics
  • Cell Line, Tumor
  • Cholesterol / pharmacology*
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / metabolism
  • Docosahexaenoic Acids / pharmacology*
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / metabolism*
  • Gene Expression Profiling
  • Gene Expression Regulation / drug effects
  • Humans
  • Oleic Acid / pharmacology
  • Oligonucleotide Array Sequence Analysis
  • RNA, Messenger / metabolism
  • Sterol Regulatory Element Binding Protein 2 / physiology*
  • Stress, Physiological / drug effects
  • Stress, Physiological / genetics

Substances

  • RNA, Messenger
  • SREBF2 protein, human
  • Sterol Regulatory Element Binding Protein 2
  • Docosahexaenoic Acids
  • Oleic Acid
  • Cholesterol